NEWS Joint Research and Development Agreement on "Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) for Patients with Myopic Chorioretinal Atrophy 2023.07.26 VIEW ALL CONTACT US For more details, questions, and quotes about PharmaBio’s services, please use the email form. MAIL FORM
Joint Research and Development Agreement on "Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) for Patients with Myopic Chorioretinal Atrophy 2023.07.26